PLK4 and cancer: Summarizing the above data, we assume that the use of PLK4 to assess the invasiveness of cancer cells needs to rely on either high-quality imaging analysis or cell sorting due to the necessity to distinguish two different phenotypes: rapidly proliferating epithelial and slow proliferating motile mesenchymal-like cells colocalized in the same tumor.